Building on the momentum from the first half of the year, our performance in this quarter has been exceptional. The open enrolment period was particularly successful, with strong outcomes across our large payer relationships. The addition of BroadPath expanded our exposure to open-enrolment-driven work and a broader payer client base. This was supported by disciplined and reliable execution. As clients navigate an evolving regulatory and profitability environment, engagements are increasingly shaped by outcome-oriented delivery models with a strong focus on cost reduction. This shift is clearly reflected in our deal pipeline with more complex constructs anchored in outcomes, and efficiency commitments on the back of technology and transformation. Our execution excellence and our continued commitment to helping our clients navigate the immediate challenges places us in a strong position. We remain confident in sustaining this momentum through the final quarter.

This quarter’s performance reflects our ability to scale rapidly while maintaining financial discipline. We delivered strong revenue growth without compromising margins, driven by operational excellence, robust cost management, and focused execution across the business. This has enabled us to maintain a healthy balance sheet, progressively reduce debt, and preserve financial flexibility. We will continue to allocate capital selectively, prioritizing investments in AI, domain capabilities, and the development of an AI-ready, healthcare-focused workforce, while maintaining a prudent approach to costs. This balance between financial discipline and strategic investment positions us well to sustain growth and margins and strengthen the long-term economics of the business.